[144 Pages Report] The global structural heart devices market is projected to reach USD 15.08 billion by 2023 from USD 8.16 billion in 2017, at a CAGR of 10.2% during the forecast period. The base year considered for this report is 2017 and the forecast period is 2018–2023.
The major players operating in the structural heart devices market are Edwards Lifesciences Corporation (US), Medtronic plc (Ireland), Abbott (US), Boston Scientific Corporation (US), and LivaNova plc (UK).
https://www.marketsandmarkets.com/Market-Reports/structural-heart-device-market-161123753.html
Scope of the Report:
The research report categorizes the structural heart devices market into the following segments and subsegments:
Structural Heart Devices Market, by Product
- Herat Valve Devices
- Surgical Heart Valves
- Transcatheter Heart Valves
- Occluders and Delivery Systems
- Annuloplasty Rings
- Other Devices
- Accessories
Structural Heart Devices Market, by Procedure
- Replacement Procedures
- TAVR Procedures
- SAVR Procedures
- Repair Procedures
- Closure Procedures
- Annuloplasty
- Valvuloplasty
- TMVR Procedures
Structural Heart Devices Market, by Region
- North America
- US
- Canada
- Europe
- Germany
- Italy
- UK
- France
- Rest of Europe (RoE)
- Asia Pacific
- Japan
- China
- India
- Rest of Asia Pacific (RoAPAC)
- Rest of the World
Available customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Geographic Analysis
- Further breakdown of the Rest of Europe structural heart devices market into Russia, Sweden, Austria, Spain, and other European countries
Company Information
- Detailed analysis and profiling of additional market players (Up to 5)
The global structural heart devices market is projected to reach USD 15.08 billion by 2023 from USD 9.28 billion in 2018, at a CAGR of 10.2% during the forecast period. The rising prevalence of structural heart diseases, regulatory approvals for new and advanced structural heart devices, favorable reimbursement scenario for structural heart procedures & devices, and increasing awareness about structural heart diseases are the major factors driving the growth of the structural heart devices market. However, low affordability and inaccessibility of cardiac surgeries in developing countries are expected to restrain the growth of this market in the coming years. In addition, a dearth of skilled personnel may affect overall procedural volumes and serve to slow the pace of market growth during the forecast period.
